Pearl Diver Credit Company Inc. Declares Monthly Preferred Dividends
PRNewswire NEW YORK and LONDON, Jan. 3, 2025 /PRNewswire/ — Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA) (the “Company”) today…
Read MoreJanuary 2025
NASA to Host Media Call Highlighting Mars Sample Return Update
WASHINGTON, Jan. 3, 2025 /PRNewswire/ — NASA Administrator Bill Nelson and Nicky Fox, associate administrator, Science Mission Directorate, will host…
Read MoreFCA US Reports Fourth-quarter and Full-year 2024 Sales Results
AUBURN HILLS, Mich., Jan. 3, 2025 /PRNewswire/ — Company’s U.S. Q4 2024 retail sales increased 1% versus same period last…
Read MoreKIA AMERICA REGISTRA LAS MEJORES VENTAS ANUALES DE TODOS LOS TIEMPOS POR SEGUNDO AÑO CONSECUTIVO
El récord de ventas anual de todos los tiempos para seis modelos de Kia eleva el volumen total en EE.…
Read MoreBaby Stroller and Pram Market to Grow by USD 1.86 Billion (2025-2029), Lifestyle Changes and Rise in Nuclear Families Boost Growth, AI-Driven Transformation – Technavio
NEW YORK, Jan. 3, 2025 /PRNewswire/ — Report with the AI impact on market trends – The global baby stroller…
Read MoreStreamlined approach to testing for heparin-induced thrombocytopenia improves diagnostic accuracy
Findings published in a special issue of ADLM’s The Journal of Applied Laboratory Medicine titled “Diagnostic stewardship in action: Advancing…
Read MoreA collaborative paradigm to improve 21st century healthcare explored in special January issue of ADLM’s The Journal of Applied Laboratory Medicine
WASHINGTON, Jan. 3, 2025 /PRNewswire/ — Diagnostic stewardship brings together healthcare professionals across specialties to ensure patients get the right…
Read MoreCNX Issues Statement on Section 45V Hydrogen Production Tax Credit Implementation Guidance
PITTSBURGH, Jan. 3, 2025 /PRNewswire/ — Today, in response to the issuance of final rules regarding the Inflation Reduction Act’s…
Read MoreIAS Announces CFO Transition
Jill Putman Appointed Interim CFO Reiterates Fourth Quarter and Full Year 2024 Outlook NEW YORK, Jan. 3, 2025 /PRNewswire/ —…
Read MoreLPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
PLATTE CITY, Mo., Jan. 3, 2025 /PRNewswire/ — LPOXY Therapeutics, Inc. (“LPOXY”), a clinical-stage biopharmaceutical company focused on innovative therapies…
Read More